維信諾(002387.SZ):連續12個月與榮耀終端簽署的日常經營類訂單累計約22.5億元
格隆匯11月26日丨維信諾(002387.SZ)公佈,公司於2020年12月15日與深圳市智信新信息技術有限公司(“深圳智信”)和榮耀終端簽署了《採購主協議》,具體產品採購信息以客户後續下發的《採購訂單》內容為準。公司於近日收到榮耀終端下發的《採購訂單PurchaseOrder》,根據訂單約定,其擬向公司採購柔性顯示屏與觸摸屏貼合組件,訂單不含税金額為7398.4萬元。
截至公吿披露日,公司連續十二個月與榮耀終端簽署的日常經營類訂單金額累計達到224850.7萬元,佔公司2020年經審計主營業務收入的106.58%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.